Valuation Gedeon Richter OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 23:12:15 28/07/2025 +04			5-day change	1st Jan Change
30.92 ^USD	+24.45%		-.--%	-

06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI
05-29	Gedeon Richter PLC Approves Dividend for the Financial Year 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,619,625	1,542,290	1,627,029	1,893,161	1,799,226	2,175,887	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	20.93%	-	-
Enterprise Value (EV) ¹	1,559,769	1,395,557	1,546,536	1,782,343	1,588,618	1,861,297	1,754,497	1,635,883
Change	-	-10.53%	10.82%	15.25%	-10.87%	17.16%	-5.74%	-6.76%
P/E Ratio	11.6x	9.94x	10.2x	7.96x	7.76x	8.33x	7.64x	6.98x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.44x	1.31x	1.19x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.7x	0.85x	0.73x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.29x	2.13x	1.98x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	1.96x	1.71x	1.49x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5.12x	4.5x	3.86x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.2x	5.37x	4.65x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	8.76x	7.59x	6.5x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11.4%	13.2%	15.4%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.2%	5.57%	6.14%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	630,595	802,755	805,158	857,545	928,962	951,724	1,023,546	1,098,192
EBITDA ¹	176,123	196,480	240,625	310,678	353,314	363,366	389,794	424,113
EBIT ¹	135,832	153,555	189,817	261,157	292,851	299,996	326,732	351,898
Net income ¹	139,626	155,581	158,850	239,244	232,335	259,474	286,154	313,070
Net Debt ¹	-59,856	-146,733	-80,493	-110,818	-210,608	-314,590	-421,390	-540,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	11,930.00	11,930.00	11,930.00
Nbr of stocks (in thousands)	185,630	185,818	185,946	182,035	182,385	182,388	-	-
Announcement Date	02/03/22	28/02/23	29/02/24	07/04/25	27/02/26	-	-	-

¹HUF in Million²HUF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.29x	7.06x	24.07x	0.83%	45.63B
OTSUKA HOLDINGS CO., LTD.	17.01x	1.89x	8.98x	1.43%	33.53B
CIPLA LIMITED	26.82x	3.3x	16.88x	0.9%	11.81B
ZYDUS LIFESCIENCES LIMITED	24.23x	4.23x	15.75x	0.73%	11.69B
KRKA, D. D.	19.49x	3.37x	12.21x	3.5%	9.12B
ONO PHARMACEUTICAL CO., LTD.	14.59x	1.91x	7.25x	3.68%	6.49B
GLENMARK PHARMACEUTICALS LIMITED	33x	3.75x	15.96x	0.24%	6.45B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	41.73x	-	-	-	5.16B
AJANTA PHARMA LIMITED	37.34x	7.14x	26.48x	1.06%	4.11B
Average	27.94x	4.08x	15.95x	1.55%	14.89B
Weighted average by Cap.	27.81x	4.43x	16.71x	1.29%